Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Microginin Synthetase - Gene Cluster and Application in Biocombinatorics

19.10.2012
<strong>Technology</strong><br>

The complete DNA sequence of the gene cluster coding for the microginin synthetase of the cyanobacterium Microcystis aeruginosa has been identified and sequenced for the first time. The microginin synthetase is a large multi-enzyme complex which catalyzes the microginin, a small linear lipopeptide belonging to the group of non-ribosomal synthesized peptides. <br><br> Microginins are synthesized by various species of cyanobacteria (“blue-green algae”) in diverse structure variants. Mircroginins represent an interesting group of unusual peptides in view of medical application as they are known to have inhibitory effects on the Angiotensin-Converting- Enzyme (ACE). Thus, microginins are potential ACE-inhibitors and represent important drug candidates to treat hypertension and associated diseases such as chronic heart failure and diabetic nephropathy.<br><br>

The new identified DNA-sequence of the microginin synthetase gene cluster can be used to identify homologue gene cluster in other cyanobacteria spe-cies and as a matter of fact for the detection of new microginin variants or microginin-like structures. Further on, novel microginin variants can be gen-erated by gene biocombinatoric experiments (gene shuffling) with the objec-tive to optimize the ACE-inhibitory effect. <br><br> <b>Benefits:</b><ul> <li>10-30 % therapies of patients treated with currently available ACE-inhibitors are ineffective -> Novel or improved ACE-inhibitors to treat hypertension are needed</li> <li>Microginins are non-toxic and show ACE-inhibitory effects</li> <li>Easy and effective method to identify microginin-producing strains of cyanobacteria</li> <li>Easy method to generate novel non-natural microginins or microginin-like structures optimizing the ACE-inhibitory effect</li> </ul> <p><strong>IP Rights</strong><br> Patent granted in US, CH, DE, FR, GB, IE, LU, SE <br><br> <strong>Patent Owner</strong><br> Humboldt-Universität zu Berlin

Further Information: PDF

ipal GmbH
Phone: +49 (0)30/2125-4820

Contact
Dr. Dirk Dantz

info@technologieallianz.de | TechnologieAllianz e.V.
Further information:
http://www.technologieallianz.de/angebote.php?sort=sag&id=2860&lang=en
http://www.technologieallianz.de

More articles from Technology Offerings:

nachricht Synthesis of novel Myrtucommulone and Analogues
25.11.2013 | TechnologieAllianz e.V.

nachricht Innovative nozzle design with homogeneous flow profile usable as divergent long-range nozzle with high penetration depth
22.11.2013 | TechnologieAllianz e.V.

All articles from Technology Offerings >>>

The most recent press releases about innovation >>>

Anzeige

Anzeige

Event News

"Start-ups and spin-offs funding – Public and private policies", 14th October 2014

12.09.2014 | Event News

BALTIC 2014: Baltic Sea Geologists meet in Warnemünde

03.09.2014 | Event News

IT security in the digital society

27.08.2014 | Event News

 
Latest News

NASA Releases IRIS Footage of X-class Flare

18.09.2014 | Physics and Astronomy

In mice, vaccine stops urinary tract infections linked to catheters

18.09.2014 | Health and Medicine

Scientists pioneer microscopy technique that yields fresh data on muscular dystrophy

18.09.2014 | Medical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>